Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
366 hedge funds and large institutions have $7.86B invested in Syneos Health, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 138 increasing their positions, 130 reducing their positions, and 58 closing their positions.
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
6% more repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 130
3% less funds holding
Funds holding: 378 → 366 (-12)
14% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 58
23% less capital invested
Capital invested by funds: $10.2B → $7.86B (-$2.29B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$137M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$61.2M |
| 3 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$56.1M |
| 4 |
Millennium Management
New York
|
+$41.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$38.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$162M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$128M |
| 3 |
KCM
Kensico Capital Management
Greenwich,
Connecticut
|
-$80.8M |
| 4 |
Morgan Stanley
New York
|
-$62.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.4M |
SYNH Hedge Fund Activity: Q1 2022 in Review
366 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q1 2022, worth a combined $7.86B — down 23% from $10.2B a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of SYNH and 50 opened new positions — a net loss of 8 holders — while 130 trimmed existing stakes and 138 added.
The largest buyer was BlackRock, adding an estimated $137M. The largest seller was Capital World Investors, cutting an estimated $162M.
- 366 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q1 2022, down from 378 in Q4 2021.
- Funds reported $7.86B of Syneos Health, Inc. Class A Common Stock stock for Q1 2022, down 23% quarter-over-quarter.
- 50 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q1 2022 and 58 closed out, a net change of -8 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q1 2022 was BlackRock, an estimated $137M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q1 2022 was Capital World Investors, an estimated $162M sold.
Based on aggregated 13F filings for Q1 2022.